Crohn's disease: open trials in Brazil

18 open trials have a site in Brazil. Registry data; only the trial team decides who can take part.

NCT07298421
A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Hoffmann-La Roche
CECIP - Centro de Estudos Clínicos do Interior Paulista, Jaú · Santa Casa de Misericordia de Porto Alegre, Porto Alegre · BR Trials - Pesquisa Clínica, São Paulo
Registry updated 2026-11-05
NCT06226883
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 2 · Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
NewData FBHC, NewData Clinical Research, Aracaju · Faculdade de Medicina da UNESP, Botucatu · Chronos Pesquisa Clínica, Brasília · Loema Clinical Research Institute and Consultants SS Ltda- i9 Clinical Research, Campinas · Pesquisare, Santo André · Clínica Hepatogastro JK, São Paulo
Registry updated 2026-11-04
NCT06937099
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Trial Treatment · Phase 3 · Eli Lilly and Company
NewData Clinical Research - Aracaju, Aracaju · L2IP - Instituto de Pesquisas Clínicas, Brasília · Loema Instituto de Pesquisa Clinica, Campinas · Fundação Universidade de Caxias do Sul (FUCS), Caxias do Sul · Centro Digestivo de Curitiba, Curitiba · Galileo Medical Research, Juiz de Fora · Hospital de Clinicas de Porto Alegre, Porto Alegre · Hospital de Clínicas de Ribeirão Preto, Ribeirão Preto · CLIAGEN Clínica de Atenção em Gastroenterologia, Especialidades e Nutrição, Salvador · Pesquisare Saude, Santo André · CPQuali Pesquisa Clínica, São Paulo · CEPIC - Centro Paulista de Investigação Clínica, São Paulo · Clínica Hepatogastro JK, São Paulo · CEDOES, Vitória · Integral Pesquisa e Ensino, Votuporanga
Registry updated 2026-11-04
NCT07483073
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Trial Treatment · Phase 2 · Eli Lilly and Company
Loema Instituto de Pesquisa Clinica, Campinas · Fundação Universidade de Caxias do Sul (FUCS), Caxias do Sul · Centro Digestivo de Curitiba, Curitiba · Centro de Pesquisa Clínica de Marília - CPCLIM, Marília · CPCLIN, São Paulo · Clínica Hepatogastro JK, São Paulo · BR Trials-Ensaios Clinicos e Consultoria, São Paulo · CPHosp Medicina, Ensino e Pesquisa (CPQuali), São Paulo · CEDOES, Vitória
Registry updated 2026-11-04
NCT07483099
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Trial Treatment · Phase 2 · Eli Lilly and Company
Loema Instituto de Pesquisa Clinica, Campinas · Fundação Universidade de Caxias do Sul (FUCS), Caxias do Sul · Centro Digestivo de Curitiba, Curitiba · Centro de Pesquisa Clínica de Marília - CPCLIM, Marília · BR Trials-Ensaios Clinicos e Consultoria, São Paulo · CPCLIN, São Paulo · CPHosp Medicina, Ensino e Pesquisa (CPQuali), São Paulo · Clínica Hepatogastro JK, São Paulo · CEDOES, Vitória
Registry updated 2026-11-04
NCT05923073
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Sociedade Campineira de Educacao e Instrucao Hospital e Maternidade Celso Pierro, Campinas · Associacao Hospitalar de Protecao a Infancia Dr. Raul Carneiro, Curitiba · Universidade Federal de Goias - Hospital das Clinicas da UFG, Goiânia · Irmandade Santa Casa de Misericordia de Porto Alegre, Porto Alegre · Hospital de Clinicas de Porto Alegre, Porto Alegre · Centro de Ciencias e Saude da Universidade Federal do Espirito Santo-Nucleo de Doencas Infecciosas, Vitória · Integral Pesquisa e Ensino, Votuporanga
Registry updated 2026-11-03
NCT06663332
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Hospital das Clinicas - UFG, Goiânia · Integral Pesquisa e Ensino, Votuporanga
Registry updated 2026-11-03
NCT07196722
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 2/3 · Janssen Research & Development, LLC
Faculdade de Medicina Universidade Federal de Minas Gerais, Belo Horizonte · Unesp - Faculdade de Medicina Da Universidade Estadual Paulista - Campus Botucatu, Botucatu · Chronos Clinica Medica Ltda, Brasília · L2IP - Instituto de Pesquisas Clínicas, Brasília · CDC - Centro Digestivo de Curitiba, Curitiba · ATO Terapias, Fortaleza · CECIP Jau - Centro de Estudos Clínicos do Interior Paulista Ltda, Jaú · Galileo Medical Research Ltda., Juiz de Fora · Cliged, Macaé · Liga Norte Riograndense Contra o Cancer, Natal · Complexo Hospitalar de Niteroi, Niterói · Hospital de Clinicas de Porto Alegre, Porto Alegre · Hospital Ernesto Dornelles, Porto Alegre · Hospital Moinhos de Vento, Porto Alegre · Platano Centro De Pesquisa Clinica LTDA, Recife · Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto, Ribeirão Preto · Clinica Ibis Medicina Ltda, Salvador · Pesquisare Saude, Santo André · Irmandade da Santa Casa da Misericórdia de Santos, Santos · Funfarme Sjrp, São José do Rio Preto · Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein, São Paulo · Hospital Santa Catarina, São Paulo · Hospital das Clinicas da Faculdade de Medicina da USP, São Paulo · BR Trials, São Paulo · Solare Trials, São Paulo · Integral Pesquisa e Ensino, Votuporanga
Registry updated 2026-11-03
NCT07577843
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Unesp - Faculdade de Medicina Da Universidade Estadual Paulista - Campus Botucatu, Botucatu · L2IP - Instituto de Pesquisas Clínicas, Brasília · CDC - Centro Digestivo de Curitiba, Curitiba · CECIP Jau - Centro de Estudos Clínicos do Interior Paulista Ltda, Jaú · Galileo Medical Research Ltda., Juiz de Fora · Cliged, Macaé · Liga Norte Riograndense Contra o Cancer, Natal · Complexo Hospitalar de Niteroi, Niterói · Hospital Ernesto Dornelles, Porto Alegre · Hospital de Clinicas de Porto Alegre, Porto Alegre · Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto, Ribeirão Preto · Clinica Ibis Medicina Ltda, Salvador · Pesquisare Saude, Santo André · BR Trials, São Paulo · Rocco And Nazato Servicos Medicos Ltda, São Paulo · Solare Trials, São Paulo · Integral Pesquisa e Ensino, Votuporanga
Registry updated 2026-11-03
NCT06233461
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 2 · Takeda
Universidade Estadual Paulista Julio De Mesquita Filho (Unesp) - Faculdade de Medicina de Botucatu, Botucatu · L2 IP Instituto de Pesquisas Clinicas Ltda, Brasília · UniversidadeEstadualde Campinas - UNICAMP, Campinas · Centro de Estudos Clnicos do Interior Paulista (CECIP), Jaú · Galileo Medical Research, Juiz de Fora · Hospital de Clínicas de Porto Alegre - HCPA, Porto Alegre · Ribeiralo Preto Medical School, University of Salo Paulo, Ribeirão Preto · Irmandade da Santa Casa da Misericórdia de Santos, Santos · Solare Trials, São Paulo
Registry updated 2026-11-02
NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Faculdade de Medicina da UNESP (Site 6308), Botucatu · Loema Instituto de Pesquisa Clinica (Site 6302), Campinas · CECIP - Centro de Estudos do Interior Paulista (Site 6316), Jaú · Hospital Ernesto Dornelles (Site 6312), Porto Alegre · Hospital de Clinicas de Porto Alegre (Site 6310), Porto Alegre · Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (USP) (Site 6311), Ribeirão Preto · Pesquisare Saude (Site 6304), Santo André · Centro de Pesquisa Kaiser - CEPEK (Site 6306), São José do Rio Preto · BR Trials - Ensaios Clinicos e Consultoria (Site 6301), São Paulo
Registry updated 2026-11-02
NCT06819891
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Hoffmann-La Roche
Newdata Clinical Trials, Aracaju · CECIP - Centro de Estudos Clínicos do Interior Paulista, Jaú · Hospital Moinhos de Vento, Porto Alegre · Hospital de Base de Sao Jose do Rio Preto, São José do Rio Preto · Hospital Sirio Libanes, São Paulo · Instituto Lobus Unimed Volta Redonda, Volta Redonda
Registry updated 2026-10-26
NCT07184931
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Sanofi
Aracaju · Barretos · Brasília · Campinas · Caxias do Sul · Goiânia · Juiz de Fora · Porto Alegre · Porto Alegre · Salvador · São José do Rio Preto · São Paulo · Teresina
Registry updated 2026-10-21
NCT07184944
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Sanofi
Sao Jose do Rio Preto Regional Faculty of Medicine Foundation-Site Number: 0760006, São José do Rio Preto
Registry updated 2026-10-21
NCT06819878
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Hoffmann-La Roche
Unesp - Faculdade de Medicina Da Universidade Estadual Paulista - Campus Botucatu, Botucatu · L2 Ip Instituto de Pesquisas Clinicas Ltda ME, Brasília · Centro de Pesquisa Sao Lucas, Campinas · Centro Digestivo de Curitiba, Curitiba · Hospital de Clínicas de Porto Alegre X, Porto Alegre · CLIAGEN Clínica de Atenção em Gastroenterologia, Especialidades e Nutrição, Salvador · BR Trials - Pesquisa Clínica, São Paulo · CPQuali Pesquisa Clínica Ltda, São Paulo
Registry updated 2026-10-16
NCT04844606
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Trial Treatment · Phase 3 · Eli Lilly and Company
Centro de Pesquisa Sao Lucas, Campinas · Hospital Pequeno Príncipe / Associação Hospitalar de Proteção à Infância, Curitiba · Universidade Federal de Goias, Goiânia · Hospital de Clinicas de Porto Alegre, Porto Alegre · Irmandade Da Santa Casa de Misericordia de Porto Alegre, Porto Alegre · Hospital Universitário Cassiano Antônio de Moraes, Vitória · Integral Pesquisa e Ensino, Votuporanga
Registry updated 2026-10-07
NCT05509777
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Trial Treatment · Phase 3 · Eli Lilly and Company
Hospital PUC-Campinas, Campinas · Hospital Pequeno Príncipe, Curitiba-PR · Hospital das Clínicas - UFG (Universidade Federal de Goiás), Goiânia · Irmandade Da Santa Casa de Misericordia de Porto Alegre, Porto Alegre · Hospital de Clinicas de Porto Alegre, Porto Alegre · NDI - Nucleo de Doenças Infecciosas, Santos Dumont · Integral Pesquisa e Ensino, Votuporanga
Registry updated 2026-10-07
NCT06227910
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Trial Treatment · Phase 3 · Takeda
Faculdade de Medicina de Botucatu, Botucatu · Hospital Universitario Cajuru, Curitiba · Centro de Estudos Clinico do Interior Paulista - CECIP, Jaú · Universidade Federal do Rio de Janeiro (UFRJ)-Hospital Universitario Clementino Fraga Filho (HUCFF), Rio de Janeiro · Pesquisare Saude, Santo André · Hospital das Clinicas of the University of Sao Paulo (Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo (HC/FMUSP)), São Paulo · Unidade de Pesquisa Clinica UPC Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo, São Paulo
Registry updated 2026-05-27

All Crohn's disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error